|
Status |
Public on Mar 22, 2021 |
Title |
IGF2BP1, a conserved regulator of RNA turnover in cancer [total RNA] |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
The IGF2 mRNA binding protein 1 (IGF2BP1) promotes tumor progression in a multitude of solid tumors and its expression is associated with adverse prognosis. The main role proposed for IGF2BP1 in cancer cells is the stabilization of mRNAs encoding pro-oncogenic factors. Several binding studies, however, revealed a plethora of putative IGF2BP1-RNA targets. Thus, at present the main, conserved target RNAs and pathways controlled by IGF2BP1 in cancer remain elusive. In this study, we present a set of genes showing a conserved pattern of deregulation in dependence of IGF2BP1 expression in cancer-derived cell lines. By incorporating publicly available data sets, we further compiled a set of RNAs probably stabilized by IGF2BP1 in cancer and characterized them. Functional enrichment analyses revealed conserved pathways influenced by IGF2BP1 in cancer.
|
|
|
Overall design |
Total RNA-Seq of different solid tumor-derived cells transfected with either control siRNAs (siC) or siRNAs directed against IGF2BP1. Three replicates per condition.
|
|
|
Contributor(s) |
Glaß M, Misiak D, Bley N, Müller S, Hagemann S, Hüttelmaier S |
Citation(s) |
33829040 |
|
Submission date |
Nov 09, 2020 |
Last update date |
Apr 13, 2021 |
Contact name |
Markus Glaß |
E-mail(s) |
markus.glass@medizin.uni-halle.de
|
Organization name |
Martin Luther University Halle-Wittenberg
|
Department |
Institute of Molecular Medicine
|
Lab |
Huettelmaier Lab
|
Street address |
Kurt-Mothes-Str. 3a
|
City |
Halle |
ZIP/Postal code |
06120 |
Country |
Germany |
|
|
Platforms (1) |
GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
Samples (24)
|
|
This SubSeries is part of SuperSeries: |
GSE161101 |
IGF2BP1, a conserved regulator of RNA turnover in cancer |
|
Relations |
BioProject |
PRJNA675536 |
SRA |
SRP291710 |